You are here

Article info

Article menu

Download PDFPDF

Electronic pages
Correspondence
Tocilizumab for polymyalgia rheumatica: a first or second line?
Free

Authors

  1. Correspondence to Professor Sergey Moiseev, Clinic of Nephrology, Internal and Occupational Diseases, Sechenov First Moscow State Medical University, Rossolimo, 11/5, Moscow 119934, Russia; clinpharm{at}mtu-net.ru
View Full Text

Citation

Moiseev S, Novikov P, Fomin V
Tocilizumab for polymyalgia rheumatica: a first or second line?
Annals of the Rheumatic Diseases 2016;75:e47.

Publication history

  • Accepted March 23, 2016
  • First published April 13, 2016.
Online issue publication 
November 21, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/